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Lymphocytes Reactivities Against Rat Neurogenic Tumor: 
Natural Killer and Suppressive Activities. 
YASUHIKO ToKURIKr 
Department of Neurosurgery, Kyoto University Medical School 
(Director: Prof. Dr. HAJIME HANDA) 
The cell-mediated immune responses between tumor cells (T 1)and lymphocytes obtained 
from spleen, thymus, lymphnode and peripheral blood lymphocytes were examined sequentially 
using direct microcytotoxicity test after subcutaneous tumor cell inoculation. T 1 tumor, neuri-
noma, was induced in syngeneic rat by transplacental administration of Ethylnitrosourea and 
showed immunological enhancement in active protection test. 
Spleen lymphocytes showed not only natural killer (.'.¥K) activity but also suppressive activity. 
Thymic and lymphnode lymphocytes showed killer activity. Peripheral blood lymphocytes 
showed mainly .'.¥K activity and partially killer activity. 
In the presence of tumor antigen, suppressive activity and killer activity were activated via 
memory cels. When the tumor antigen was weak, suppressive activity was activated earlier 
than kiler activity, 3 days after inoculation in suppressive activity and 7 days in killer activity 
resp町tively. This suppressive activity inhibited not only killer activity but also :¥K activity which 
was thought to be identical wi出 prethymiccelk On advancing of the tumor development, 
memory cels were neutralized by excessive antigenフandsuppressive activity was decreased earlier 
than kiler activity, which suggested that suppressive activity was intermediated by shorter life 
span lymphocytes than killer activity. NK activity was also decreased in terminal stage. 
When the tumor antigen was strong, which was examined using earlier passaged tumor, 
suppressive activity was hard to be activated and killer aεtivity was strongly activated. 
Key町出 Immur山 gicalenhancement, ~licro句totoxicity 附， Natu凶 killercel, Suppressor cel, Int町 e凶日l
mculation. 
！~I語： Immun叫i山山icem叫細胞障害試験，ナチユラ Jレキラー細胞，サプレソサー細胞，脳内接種
resent address: Department of Neurosurgery, Kyoto University Medical School, Sakyo-ku, Kyoto, 606,] a pan. 
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When inoculated in the brain tissue, which was thought to be different site of the lympho 
reticular response by the host, suppressive activity was not activated at all and killer activity was 
strongly activated, and antigenicity caused no differences in cytotoxicity. 
I believe it will be required in tumor immunotheraphy to increase NK and killer activity、
















今回実験に用いた Ti腫蕩ば， mVi¥"Oの activepro 
tection testで，特Iこ腫場接種後早期［こ immunological
enhancementの現象をみた腫蕩で，乙の enhancement


























盤投与（40mg/kg, 21th day of pregnancy) Iとより，













































































4mlのFicoll-Paque(Pharmacia Fine Chemicals AB. 
Sweden）の上IC3mlずつ静かに重畳し， l.600r.p.m.
Fig. 1. Illustration of the transcarosal tumor ino・
culation. 
Com. C.: common carotid artery, Int. C. 
internal carotid artery, Ext. C external 
carotid artery, Stap.: stapedial artery, Stars 



















Microcytotoxicity test には， Falcon#3034 microtest 
plate (Falcon Plastic Co. Lit.）を用いた.20劣FCS加
:¥IEi¥Iで2x10•/ml lζ濃度調整した T1細胞を， micro
titer pipetteを用いて 10μ1(2×103 cells/well）ずつ各
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支障をきたす為である． ただちに 37。Cの PBSでl
回洗浄し，底部lこ残った培養液の蛋白成分を稀釈した
のち， pureethanolで5分間固定， May Griineward・ 













elの細胞数の平均値Cl=lーー 一、ントロー ノレ wellの緬面証(j)平耳百
として算出し




















Table 2. Direct microcytotoxicity test comparing 
between untreated (Ct) rat lymphocytes 
from each organ. 
Effector I TL I ~~~~2'；干l田5I % of In.山 a
ls I ratio I （~~~~ ・ ~；ll~ I cytotoxicity I Y… 
control I ! 251. 4士62.11 I 
Ct Sp I 10 I 195. 6土42.s 1 22. 2 I > o.s 
Ct Th I 10 i 156. 6土23.8! 37.8 ！く0.2
Ct Ln I 10 I 144. 1土65.91 42.8本 iく0.005 
Ct PBL I 10 ' 183. 2土48.ll 27.1 I <0.01 
t叫 I i 208. 3士48.1
ぐtSp I 100 I 21. 2土16.7 I 89. 9本 1<o. oos 
Ct Th I 100I170.6土52.3 I 18. 1 I > o.s 
Ct Ln I 100 I 86. 5土73.2 I 58. 5本｜ くo.05 
Ct PBL I 100 j 35. 2士10.21 83. 2本｜くo.01 
control 282.5土67.2
Ct Sp I 200 I 3. 0土 o.81 99.9* I <0.001 
Ct Th I 200 I 306. 8土64.3I -8. 6 Iく0.4
Ct Ln I 200 ' 215. 2土51.8 I 23. 9 I > o.s 
Ct PBL I 200 i 41. 8土19.6 I 85. 2本｜く0.005
Sp: spleen cels, Th: thymic cels, Ln: lymph-node 
cels, PBL: peripheral blood lymphocytes. 
(*) means statistical significance which p-value is 
les than 0.05. % of cytotoxicities are claculated 
in a comparisone to the control which tested the 
medium only. 
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Table 3. Direct microcytotoxicity test comparing between the three states using spleen cels 
(a), thymic cells (b), lymph-node cells (c) and peripheral blood lymphocytes (di. 
b a 
I Mean val s '. 
E長ctor; TL I of survival I t-value I p- 1 
cels ratio i tum…ns i I 
Ct Sp I 10 I 195. 6土42.81 
Se Sp I 10 I 205. 6土85.6I 0.209 I >0.5 
Tu Sp I 10 I 128.1±54. 5 I 1.882 Iく0.1
Ct Sp 100 I 21. 2± 16. 7 
Se Sp I 100 I 82. 6±41. 7 I 3.361 *I<0. 01 
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TL I Mean v 
ratio I of survival t-value p-value 
I tumor cels 
10 I 156. 3±23. 8 
10 I 162. 5土58.31 0.219 >0.5 
10 I 170.0±74.4 i 0.486' >0.5 
100 I 170. 6土52.3
100 51. 5土22.9 4. 530* < 0.005 
100 ' 79. 6±71. 7 2. 426＊く0.05
! 200 I 306. 8土64.3I 
200 ' 143. 4±72. 8 3. 259ホ＜0.01















Se PBL I 100 
Mean values TL of survival 
tumor cels 
t-value p-value 
10 I 183. 2土48.1
10 I 154. 7±52. 6 
10 216. 3±86. 9 
0. 976 <O. 4 
1. 877 く0.1
35. 2± 10. 2 
31. 8土14.3 ' 0.215 > 0.5 
Tu PBL 100 168. 5土98.1 3.198＊く0.025
Ct PBL I 200 41. 8土19.6
Se PBL I 200 I 32.6±16.2 1.856 ・ <0.1 
Tu PELI 200 ，凶日2.5 I 4.悶 I<0.00 
Ct: controlled state, Se: sensitized state, Tu: tumor-bearing state. 
(*l means statistical significance which p-value is less than 0.05. t-values and p-values are calculated in 




































































































100 200 TL ratio: 10 
(c) (d) 
Fig. 2. Representation m五guresof the table・3 (a), （し）、（c)and (d). 
open bar : controlled rat lymphocytes 
dotted bar : sensitized rat lymphocytes 




T1細胞 1x105個を皮下に接種後， 3日， 7日， 10








































































Fig. 3. Cytotoxic acti¥'itics of spleen cells (a), thymicαls (b) and peripheral blood lym・ 
phocytes (c) from tumor-bearing rat during the course of tumor development. 
（本） shown at day 0 represe mean、山門 ofcytotoxi山 esobtained from con叫led
rat at each of the experiments. % of 《、ytotoxicitiesare calculated in a comparison 

































Fi邑.4. 7 days after direct intracereliral inoculation. 
Ti cells around a capillary. Lympho・reti-
cular cel reaction "°'" not observed. 
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Fi邑.5. Cytotoxic activity of spleen cells (a), thymic cells (h) and peripheral blood 
lymphocytes (c) from tumor bearing rat during the cour'e of tumor d引 e
lopment after subcutaneous inoculation(.) and intracerebral inoculation 
（企）．
（女lshown at day 0 represent mean values of cytotoxicities obtained from 
controlled rat at each of the experiments. 
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Fig・ 6・ ~ytotoxic activity of spleen cells (a), thymic cells (b) and peripheral blood lym-
phocytes (c) from tumor bearing rat at day 7 and 14 after transcarosal tumor cel 
inoculation with （口） or without (.) ultrasonic brain damaize. 
The results after subcutaneous <el and direct intracerebr~l （企） inoculation are 
also shown. (*I shown at day 0 represent mean values of cytotoxicities obtained 
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Fl2. 7. Cytotoxic activity of spleen cells (a), thymic cels (b) and peripheral blood lym-
phocytes (c) from either early passaged (open symbol) or old passaged (black sym-
bol) tumor bearing rat during the course of tumor development after subcutaneous 
(circle) and intracerebral (triangle) inoculation~ (0): subcutaneous inoculation of 
the early passaged tumor, （・）: subcutaneous inoculation of the old passaged tu-
mor, （ム）: intracerebral inoculation of the early passaged tumor, (.A) intracere?ral 
inoculation of the old passaged tumor. （女） shown at day 0 represent mean values 
of cytotoxidties obtained from controlled rat at each of the experiments. 
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Fig. 8. Sham test. Cytotoxic activity of spleen cells (circle), thymic cells (triangle) and 
peripheral blood lymphocytes (square) after needle puncture with (open symbol) or 
without (black symbol) saline i吋ection;(.I: spleen cells, needle puncture only. 
(0): spleen cells, needle puncture with saline injection. （企I:thymic cels, needle 
puncture only. （ム）: thymic cells, needle puncture with saline injection. (.) 
peripheral blood lymphocytes, needle puncture only. （口）： peripheral blood lym・ 



























する因子－suppressorT cel (Ts) の研究も進められ
ている．
著者等は， ethylnitrosoureaで誘発した脳腫蕩の性質









乙の NKcel l乙関しては， TaiA 等（1980)33）は7
腫場と生体の免疫反応をみる場合，腫湯の性質の違 ウスの年令によって NK activity IL差がみられると報
いはもちろんであるが，免疫反応の担い手であるリン 告している．一方 BroockCG.等（1980)4＞によれば，
























更に HerbermanRB.等（1978）日｝によれば， pre thy-
mic T cel (T1, T2）がsuppressorT celの影響を受け
















Schechter B.等（1979)2町のいう memoryT cel (Tm) 
の観念が必要になる．すなわち，抗原刺激を受けた




mory cel によって killerT celより suppressorT cel 
が先に，より強く activateされる．やがて suppressor
T cel, killer T cel共刺激されるようになる．腫蕩接
種後10日目頃になり腫蕩の増殖がすすみ抗原が増加し
てくると， memorycel はneutralizeされてしまう．
suppressor T cel の lifespan (i killer T celの life
spanより短かいと考えられるのでm，乙の状態になる
とactiveな suppressorT celは消滅してしまい， sup-




一方， RiccardiG.等（1980)26）によると， NK cel 
の activityの低下は suppressorT celと同様早いと報
告している．本実験系では，末梢血リンバ球で，接種
後7日目， 10日目でも強い障害性を維持していた． t 
棺血リ ンパ球には NKcelのみでなく killerT celも













PS.等（1979)17）は， pre-suppressorT celという sub-
populationを考えているが， Fig.9ではそれぞれ Tc,
Tsと表現した 乙れは matureT celであるが，実際
にkiller,suppressorと確認されるのは， memorycel 




違によって，active killer T cel kもactivesuppressor 
T cel にも変化し得る，すなわち pre-killerT celと
pre-suppressor T cel は同ーの subpopulationではな
いかとも考えられるが，推測の域はでない．
少なくとも， killercel, suppressor cel というより
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l吋ocyte
－一一＋ pre Tl ； ＋山＝州日川fic ?> 
Tc Ts 
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Tc* I ~is* 
Ag i 
<specific) 
Fig. 9. Hypothesis of correlation between sub-
populations of the lymphocytes, natural 
killer cells (NK), cytotoxic or killer T 
cells (Tc) and suppressor T cells (Ts). 
Lymphocytes wil mature to cytotoxic T 
cels and suppressor T cells via pre-thy-
mic cel types (pre-Tl, and pre T2). 
Then mature Tc and Ts will be immu-
nized to active TC (TC* I and active Ts 
(Ts*) by the specific antigens (Ag) via 
memory T cells (Tm), and this active Ts 
will suppress not only the pathway in 
、hichTc mature to active Tc but also 
pre-mature cels, pre-Tl or pre-T2, 
which may Le identical with natural 
killer cels. 
は， killeractiv町，suppressiveactivityと表現するべき
であると恩われるが本文中用いた NKcel, killer T 































場合， killeractivityはみられるが， suppressiveactivity 
は誘発されないと考えられる．また胸腺リンパ球では，
末期にみられた細胞障害性の低下がより早期にみられ 主注




従って suppressiveactivityの誘発はなく， kileracti- i！嘗：
































ある．一方， lowdose irradiation, cyclophosphamide, 










(1973)7＞が報告したように， nude mouse における



















常IC少ないが，抗原刺激により， suppressive activity 
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